Bioequivalence and Bioavailability Forum 09:22 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Potvin C or B? [Two-Stage / GS Designs]

posted by Helmut Homepage - Vienna, Austria, 2012-06-02 18:54  - Posting: # 8656
Views: 8,616

Gossip:

One regulator (I leave it to your imagination which one of EMA’s working parties he belongs to) told me that

Our [i.e., his agency’s] statisticians don’t believe* that in Potvin’s Method C the patient’s risk is preserved at ~5%. They suggest to use only Method B because application of Pocock’s α 0.0294 is well known.

I suggested to tell them to have a closer look at the empiric alphas (the endless tables in the paper). BTW, specifically Method C (not B!) is recommended by the FDA and in the recent Canadian GL.



Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,914 posts in 4,036 threads, 1,283 registered users;
online 23 (0 registered, 23 guests [including 14 identified bots]).

Statistics is, or should be, about scientific investigation
and how to do it better, but many statisticians believe
it is a branch of mathematics.    George E.P. Box

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed